Biohaven (BHVN) Assets Average (2022 - 2026)
Biohaven (BHVN) posted Assets Average of $458.9 million for Q1 2026, up 6.66% sequentially from $430.3 million in Q4 2025, and down 14.54% YoY from $537.0 million in Q1 2025.
Biohaven (BHVN) Assets Average (2022 - 2026) Analysis & Trends
Biohaven has reported Assets Average for 5 years, with the latest figure at $458.9 million in Q1 2026.
- Quarterly Assets Average fell 14.54% year-over-year to $458.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $458.9 million (down 14.54% YoY) and the FY2025 annual result came in at $533.3 million, down 5.47% from the prior year.
- Assets Average rose to $458.9 million in Q1 2026 per BHVN's latest filing, from $430.3 million in the prior quarter.
- Over five years, Assets Average peaked at $640.2 million in Q1 2023 and troughed at $398.7 million in Q4 2022.
- A 5-year average of $498.6 million and a median of $490.2 million in 2024 frame the typical range for Assets Average.
- The widest YoY moves for Assets Average: up 25.64% in 2024, down 27.22% in 2024.
- Over 5 years, Assets Average stood at $398.7 million in 2022, then grew by 12.35% to $448.0 million in 2023, then gained by 25.64% to $562.8 million in 2024, then decreased by 23.55% to $430.3 million in 2025, then grew by 6.66% to $458.9 million in 2026.
- According to Business Quant data, Assets Average over the past three periods registered $458.9 million, $430.3 million, and $479.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 3.29 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.86 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 16.08 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.34 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.09 Bn |
| 10 | Biohaven | 2.21 Bn | 1.94 Bn | - | 418.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 418.57 Mn |
| Mar 31, 2026 | 458.93 Mn |
| Dec 31, 2025 | 430.29 Mn |
| Sep 30, 2025 | 479.77 Mn |
| Jun 30, 2025 | 504.68 Mn |
| Mar 31, 2025 | 537.03 Mn |
| Dec 31, 2024 | 562.82 Mn |
| Sep 30, 2024 | 546.58 Mn |
| Jun 30, 2024 | 500.59 Mn |
| Mar 31, 2024 | 465.87 Mn |
| Dec 31, 2023 | 447.97 Mn |
| Sep 30, 2023 | 444.74 Mn |
| Jun 30, 2023 | 562.63 Mn |
| Mar 31, 2023 | 640.15 Mn |
| Dec 31, 2022 | 398.71 Mn |